We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.62%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.1B
AUM Growth
+$989M
(+9.8%)
Cap. Flow
+$432M
Cap. Flow
% of AUM
3.9%
Top 10 Holdings %
Top 10 Hldgs %
14.96%
Holding
1,372
New
66
Increased
556
Reduced
543
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$45.7M |
| 2 |
Morgan Stanley
MS
|
+$44.1M |
| 3 |
Eli Lilly
LLY
|
+$32.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$30.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$29.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$51.6M |
| 2 |
Oracle
ORCL
|
+$40M |
| 3 |
Equity Residential
EQR
|
+$34.6M |
| 4 |
Citigroup
C
|
+$31.3M |
| 5 |
ExxonMobil
XOM
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.49% |
| 2 | Technology | 14.87% |
| 3 | Financials | 14.25% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Industrials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FINL
901
DELISTED
Finish Line
FINL
| $890K | 0.01% |
62,525
-21,868
| -26% | -$367K |
|
902
Marvell Technology
MRVL
$168B
| $888K | 0.01% |
58,206
-44,178
| -43% | -$680K |
|
|
SBNY
903
DELISTED
Signature Bank
SBNY
| $887K | 0.01% |
5,978
-3,803
| -39% | -$589K |
|
904
Coty
COTY
$2.42B
| $880K | 0.01% |
48,540
-9,703
| -17% | -$183K |
|
905
Raymond James Financial
RJF
$33.8B
| $880K | 0.01% |
17,309
-17,544
| -50% | -$893K |
|
906
Prestige Consumer Healthcare
PBH
$2.38B
| $873K | 0.01% |
15,716
-45,655
| -74% | -$2.52M |
|
907
Fidelity National Financial
FNF
$13.9B
| $869K | 0.01% |
32,161
+3,769
| +13% | +$95.9K |
|
|
ECHO
908
EchoStar
ECHO
$24.4B
| $869K | 0.01% |
18,820
| – | – |
|
909
Onto Innovation
ONTO
$12.9B
| $868K | 0.01% |
28,508
| – | – |
|
|
CCRN
910
DELISTED
Cross Country Healthcare
CCRN
| $862K | 0.01% |
59,999
+302
| +0.5% | +$4.45K |
|
911
Interparfums
IPAR
$3.99B
| $859K | 0.01% |
23,495
+8,130
| +53% | +$282K |
|
|
NXGN
912
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $857K | 0.01% |
56,240
+17,646
| +46% | +$260K |
|
913
Invesco QQQ Trust
QQQ
$453B
| $853K | 0.01% |
6,445
+4,312
| +202% | +$551K |
|
914
Lennar Class A
LEN
$19.8B
| $851K | 0.01% |
17,459
| – | – |
|
|
BRKL
915
DELISTED
Brookline Bancorp
BRKL
| $850K | 0.01% |
54,319
| – | – |
|
|
LDL
916
DELISTED
Lydall, Inc.
LDL
| $849K | 0.01% |
15,837
+5,633
| +55% | +$320K |
|
917
Ares Capital
ARCC
$13.5B
| $845K | 0.01% |
+48,601
| New | +$840K |
|
918
Atmos Energy
ATO
$28.8B
| $845K | 0.01% |
10,697
-1,175
| -10% | -$90.2K |
|
919
3D Systems Corp
DDD
$431M
| $845K | 0.01% |
56,469
+17,104
| +43% | +$268K |
|
920
National Fuel Gas
NFG
$7.82B
| $843K | 0.01% |
+14,133
| New | +$832K |
|
|
CDR
921
DELISTED
Cedar Realty Trust, Inc
CDR
| $843K | 0.01% |
25,440
+7,948
| +45% | +$305K |
|
|
ENIA
922
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $839K | 0.01% |
80,728
| – | – |
|
923
Fair Isaac
FICO
$24.3B
| $838K | 0.01% |
+6,495
| New | +$824K |
|
924
Koppers
KOP
$943M
| $837K | 0.01% |
+19,770
| New | +$830K |
|
925
UGI
UGI
$7.74B
| $835K | 0.01% |
16,907
-4,393
| -21% | -$209K |
|
Similar funds
HF
KBC Group's Q1 2017 Portfolio in Review
As of Q1 2017, KBC Group held 1,372 positions worth $11.1B, up 9.8% from $10.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
KBC Group deployed $432M of net new capital in Q1 2017, opening 66 new positions and adding to 556 existing holdings. Its largest new stake was LogMein, Inc.: 156,863 shares worth $15.3M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $51.6M trimmed.
- KBC Group's largest Q1 2017 buy was LogMein, Inc.: 156,863 shares worth $15.3M.
- KBC Group added most to Microsoft in Q1 2017, an estimated $45.7M increase.
- KBC Group's biggest Q1 2017 reduction was Pfizer, cutting an estimated $51.6M.
- KBC Group fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $16.2M.
- KBC Group's ten largest holdings make up 15% of its $11.1B portfolio in Q1 2017.
- KBC Group opened 66 new positions and closed 69 in Q1 2017.
- KBC Group's portfolio value rose 9.8% quarter-over-quarter to $11.1B.
Based on KBC Group's 13F filing for Q1 2017, filed 10 May 2017.